Cadrenal Therapeutics, Inc. Common Stock (CVKD) — Financial Flexibility Index
Cadrenal Therapeutics, Inc. Common Stock (CVKD) has a Financial Flexibility Index of -2.82x as of March 2026. Free cash flow of $-3.00 Million (operating CF $-3.00 Million minus capex $3.00) represents -3% of total liabilities ($1.06 Million). Check Cadrenal Therapeutics, Inc. Common Stock (CVKD) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Cadrenal Therapeutics, Inc. Common Stock Financial Flexibility Index (2022–2025)
Historical Financial Flexibility Index trend for Cadrenal Therapeutics, Inc. Common Stock across 4 annual periods. For the full cash flow conversion analysis, see CVKD cash generation efficiency.
Annual Financial Flexibility Index for Cadrenal Therapeutics, Inc. Common Stock (2022–2025)
Year-by-year free cash flow to debt coverage for Cadrenal Therapeutics, Inc. Common Stock. Explore CVKD debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -7.93x | $-12.60 Million | $-12.60 Million | $1.59 Million | ▼ -189.6% |
| 2024 | -2.74x | $-7.35 Million | $-7.36 Million | $2.68 Million | ▲ +35.8% |
| 2023 | -4.27x | $-3.53 Million | $-3.53 Million | $826.88K | ▼ -2145.6% |
| 2022 | -0.19x | $-1.20 Million | $-1.20 Million | $6.33 Million | — |